Dabigatran etexilate for preventing venous thromboembolism after hip or knee replacement surgery

  • Technology appraisal guidance
  • TA157
  • Published: 
Download guidance (PDF)

9 Update information

July 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. This does not affect the meaning or intent of the guidance.

February 2014: The implementation section was updated to clarify that dabigatran etexilate is recommended as an option for the prevention of venous thromboembolism after hip or knee replacement surgery.

ISBN: 978-1-4731-6509-0